At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
Argos +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Trial Comparing Prediction Accuracy of Two Swept Source Optical Coherence Tomography Biometers
In Brief
An observational study evaluating Argos and IOLMaster 700 for Cataract. Completed, enrolled 80 participants across 1 site.
Detailed Summary
To assess if the Alcon Argos Biometer utilizing the Barrett Universal II formula for IOL calculations can give a non-inferior outcome when compared to the Zeiss IOL master 700 utilizing the (PCA) with the Barrett Universal II (TK) formula, when comparing the (mean absolute prediction error of the predicted target spherical equivalencies).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJul 2021
Primary CompletionSep 2021
First PostedFeb 2023
TodayJul 2026
First PostedFeb 28, 2023
Enrollment StartJul 19, 2021
Primary CompletionSep 15, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 3.3 years ago
Interventions
Argosother
Biometry measurements first with the Argos device, then the IOLMaster 700 device.
IOLMaster 700other
Biometry measurements first with the IOLMaster 700 device, then the Argos device.